What is the recommended duration of nortriptyline (tricyclic antidepressant) prescription for the prevention of post-herpetic neuralgia after shingles?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: December 2, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Duration of Nortriptyline for Post-Herpetic Neuralgia Prevention

The evidence supports starting nortriptyline at the time of acute shingles diagnosis and continuing for approximately 90 days (3 months), with the option to taper after 6 weeks if the patient is pain-free, or to continue and escalate the dose if pain persists at 6 weeks. 1

Timing and Duration Strategy

Early Initiation (Prevention Phase)

  • Start nortriptyline 10-25 mg at bedtime immediately upon diagnosis of acute shingles to reduce the incidence of post-herpetic neuralgia by approximately 50% 2
  • The timing between rash onset and treatment initiation is critical—earlier treatment correlates very strongly with better outcomes 1
  • Begin within the first 6 days of rash onset when possible 3

Assessment at 6 Weeks

  • Review the patient at 6 weeks after shingles onset 1
  • If pain-free at 6 weeks: Continue low-dose nortriptyline for another 4-6 weeks (total ~10-12 weeks), then taper and discontinue 1
  • If pain persists at 6 weeks: Increase the dose to 50-75 mg at bedtime over 2-3 weeks and continue treatment 2, 1

Extended Treatment for Established PHN

  • For patients with established post-herpetic neuralgia (pain persisting ≥3 months), continue nortriptyline indefinitely until pain relief is achieved 4
  • Post-herpetic neuralgia may persist for months to years, and some patients require long-term treatment with no specified maximum duration 4
  • If tricyclic antidepressants fail to provide relief within 8 weeks of adequate dosing, refer for specialist pain management 2

Dosing Algorithm

Initial Dosing

  • Start at 10-25 mg at bedtime 5, 2
  • Increase every 3-7 days as tolerated 5
  • Target dose: 25-100 mg at bedtime 5
  • Therapeutic range for established PHN: 50-75 mg 2, 1

Rationale for Nortriptyline

  • Nortriptyline is preferred over amitriptyline due to superior tolerability with equivalent analgesic benefit (NNT = 2.64) 4, 6
  • Common side effects include dry mouth, constipation, and sedation, which are less pronounced than with amitriptyline 5

Key Clinical Considerations

Prevention vs. Treatment

  • Preventive therapy (started during acute shingles) requires shorter duration—approximately 90 days total if pain-free at 6 weeks 1
  • Treatment of established PHN (pain ≥3 months after rash) may require indefinite continuation until pain resolves, as the condition can persist for months to years 4

Monitoring and Reassessment

  • The probability of pain relief correlates strongly with the brevity of the interval between rash onset and antidepressant initiation 1
  • Periodic reassessment is recommended, as post-herpetic neuralgia may improve over time 4
  • Patients who received antiviral treatment for acute shingles achieve pain relief faster when treated with nortriptyline 1

Common Pitfalls to Avoid

  • Do not wait for PHN to develop before starting treatment—pre-emptive low-dose tricyclics from the time of shingles diagnosis significantly reduces PHN incidence 2
  • Do not discontinue prematurely—if pain is present at 6 weeks, the dose should be increased rather than stopped 1
  • Do not use conventional analgesics or carbamazepine as primary therapy—these have little to no value for PHN 2
  • In elderly patients, start with lower doses (10 mg) and titrate more slowly to minimize side effects 6

References

Research

The management of postherpetic neuralgia.

Postgraduate medical journal, 1997

Guideline

Treatment Options for Post-Herpetic Neuralgia

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Management of Postherpetic Neuralgia in Elderly Women

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.